CASIF Casi Pharmaceuticals, Inc.
Fundamentals / CIK 0001962738 / USDCasi Pharmaceuticals, Inc. reported $20.71M in revenue and a net loss of $48.06M for the fiscal year ended December 31, 2025 (down 27.4% year over year), with a 48.6% gross margin and a -217.3% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CASIF in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$20.71M -27.4% YoY
-
Operating Income FY 2025-$45.01M -217.3% margin
-
Net Income FY 2025-$48.06M -232.0% net margin
-
Diluted EPS FY 2025-$2.59 Split-adjusted
-
Free Cash Flow FY 2025-$20.77M -100.3% FCF margin
-
Cash & ST Investments Dec 31, 2025$5.63M Total debt: $22.24M
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $20.71M | $28.54M | $33.88M | $43.11M | $30.17M | $15.14M |
| Cost of Revenue | $10.64M | $17.39M | $13.83M | $15.83M | $12.56M | $9.51M |
| Gross Profit | $10.08M | $11.15M | $20.05M | $27.28M | $17.61M | $5.63M |
| Research & Development | $6.31M | $8.92M | $9.86M | $16.00M | $14.42M | $11.47M |
| Selling, General & Admin | $46.61M | $41.44M | $41.84M | $37.77M | $38.41M | $27.48M |
| Operating Income | -$45.01M | -$39.62M | -$25.08M | -$34.03M | -$41.52M | -$52.78M |
| EBITDA | -$43.81M | -$38.32M | -$22.58M | -$32.83M | -$41.02M | -$52.18M |
| Interest Expense | -- | -- | -- | $0 | $2.9K | $3.1K |
| Income Before Tax | -$45.87M | -$38.07M | -$26.29M | -$37.43M | -$35.84M | -$47.51M |
| Income Tax Expense | -- | $0 | -$81K | $1.98M | $0 | $0 |
| Net Income | -$48.06M | -$39.26M | -$26.96M | -$41.01M | -$36.65M | -$48.29M |
| Basic EPS | -$2.59 | -$2.56 | -$2.02 | -$3.01 | -$2.69 | -$4.37 |
| Diluted EPS | -$2.59 | -$2.56 | -$2.02 | -$3.01 | -$2.69 | -$4.37 |
| Basic Shares Outstanding | 18.5M | 15.3M | 13.4M | 13.6M | 13.6M | 11.0M |
| Diluted Shares Outstanding | 18.5M | 15.3M | 13.4M | 13.6M | 13.6M | 11.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $5.63M | $13.47M | $17.08M | $47.11M | $38.70M |
| Short-Term Investments | -- | -- | $12.01M | $1.46M | $9.87M |
| Cash & Short-Term Investments | $5.63M | $13.47M | $29.09M | $48.57M | $48.57M |
| Accounts Receivable, Net | $4.09M | $15.35M | $9.55M | $12.97M | $9.80M |
| Inventory | $1.60M | $5.25M | $15.88M | $6.14M | $1.91M |
| Total Current Assets | $13.46M | $39.58M | $59.34M | $73.42M | $61.97M |
| Property, Plant & Equipment, Net | $6.97M | $7.87M | $9.24M | $11.83M | $12.71M |
| Intangible Assets | $221K | $238K | $1.84M | $1.06M | $12.20M |
| Long-Term Investments | $1.72M | $1.91M | $1.69M | $4.40M | $40.13M |
| Other Non-Current Assets | $740K | $587K | $766K | $1.06M | $2.18M |
| Total Non-Current Assets | $12.19M | $14.10M | $15.92M | $22.81M | $76.33M |
| Total Assets | $25.65M | $53.67M | $75.27M | $96.23M | $138.3M |
| Accounts Payable | $1.06M | $2.72M | $4.44M | $3.29M | $2.22M |
| Short-Term Debt | $19.19M | $18.39M | -- | -- | -- |
| Other Current Liabilities | $2.23M | $1.33M | $1.12M | $648K | $519K |
| Total Current Liabilities | $49.67M | $36.45M | $16.73M | $17.00M | $13.19M |
| Long-Term Debt | -- | -- | $18.89M | -- | -- |
| Other Non-Current Liabilities | $13.26M | $15.37M | $15.48M | $12.30M | $14.32M |
| Total Non-Current Liabilities | $13.26M | $15.37M | $34.38M | $12.30M | $17.15M |
| Total Liabilities | $62.93M | $51.82M | $51.10M | $29.30M | $30.34M |
| Total Debt (incl. Leases) | $22.24M | $22.14M | $21.24M | $1.34M | $2.17M |
| Common Stock | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$748.1M | -$700.1M | -$660.8M | -$637.2M | -$605.6M |
| Accumulated Other Comp. Income | -$1.78M | -$1.77M | -$1.20M | -$703K | $1.95M |
| Total Stockholders' Equity | -$37.28M | $1.85M | $24.16M | $44.57M | $84.50M |
| Total Equity | -$37.28M | $1.85M | $24.16M | $44.57M | $84.50M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $5.63M | $13.47M | $17.08M | $47.11M | $38.70M |
| Short-Term Investments | -- | -- | $12.01M | $1.46M | $9.87M |
| Cash & Short-Term Investments | $5.63M | $13.47M | $29.09M | $48.57M | $48.57M |
| Accounts Receivable, Net | $4.09M | $15.35M | $9.55M | $12.97M | $9.80M |
| Inventory | $1.60M | $5.25M | $15.88M | $6.14M | $1.91M |
| Total Current Assets | $13.46M | $39.58M | $59.34M | $73.42M | $61.97M |
| Property, Plant & Equipment, Net | $6.97M | $7.87M | $9.24M | $11.83M | $12.71M |
| Intangible Assets | $221K | $238K | $1.84M | $1.06M | $12.20M |
| Long-Term Investments | $1.72M | $1.91M | $1.69M | $4.40M | $40.13M |
| Other Non-Current Assets | $740K | $587K | $766K | $1.06M | $2.18M |
| Total Non-Current Assets | $12.19M | $14.10M | $15.92M | $22.81M | $76.33M |
| Total Assets | $25.65M | $53.67M | $75.27M | $96.23M | $138.3M |
| Accounts Payable | $1.06M | $2.72M | $4.44M | $3.29M | $2.22M |
| Short-Term Debt | $19.19M | $18.39M | -- | -- | -- |
| Other Current Liabilities | $2.23M | $1.33M | $1.12M | $648K | $519K |
| Total Current Liabilities | $49.67M | $36.45M | $16.73M | $17.00M | $13.19M |
| Long-Term Debt | -- | -- | $18.89M | -- | -- |
| Other Non-Current Liabilities | $13.26M | $15.37M | $15.48M | $12.30M | $14.32M |
| Total Non-Current Liabilities | $13.26M | $15.37M | $34.38M | $12.30M | $17.15M |
| Total Liabilities | $62.93M | $51.82M | $51.10M | $29.30M | $30.34M |
| Total Debt (incl. Leases) | $22.24M | $22.14M | $21.24M | $1.34M | $2.17M |
| Common Stock | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$748.1M | -$700.1M | -$660.8M | -$637.2M | -$605.6M |
| Accumulated Other Comp. Income | -$1.78M | -$1.77M | -$1.20M | -$703K | $1.95M |
| Total Stockholders' Equity | -$37.28M | $1.85M | $24.16M | $44.57M | $84.50M |
| Total Equity | -$37.28M | $1.85M | $24.16M | $44.57M | $84.50M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$48.06M | -$39.26M | -$26.26M | -$40.26M | -$35.84M | -$47.51M |
| Depreciation & Amortization | $1.20M | $1.30M | $2.50M | $1.20M | $500K | $600K |
| Stock-Based Compensation | $2.99M | $1.31M | $7.22M | $7.01M | $7.77M | $7.82M |
| Change in Receivables | $11.25M | -$5.79M | $3.42M | -$3.17M | -$5.16M | -$3.35M |
| Change in Inventory | $2.50M | $5.83M | -$9.74M | -$4.23M | -$551K | $3.19M |
| Change in Payables | -$1.66M | -$1.72M | $1.15M | $1.07M | $1.49M | -$1.54M |
| Operating Cash Flow | -$20.75M | -$29.22M | -$19.97M | -$21.09M | -$26.84M | -$25.89M |
| Capital Expenditure | -$16K | -$223K | -$204K | -$5.61M | -$8.95M | -$1.50M |
| Free Cash Flow | -$20.77M | -$29.45M | -$20.17M | -$26.70M | -$35.79M | -$27.39M |
| Investing Cash Flow | $951K | $11.24M | -$9.67M | $31.16M | -$20.69M | -$20.72M |
| Share Repurchases | -- | -- | -$278K | -$3.27M | -- | -- |
| Financing Cash Flow | $11.25M | $15.43M | -$907K | -$3.27M | $29.64M | $47.15M |
| Net Change in Cash | -$7.84M | -$3.62M | -$30.03M | $8.41M | -$18.36M | $3.44M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Gross Margin | 48.6% | 39.1% | 59.2% | 63.3% | 58.4% | 37.2% |
| Operating Margin | -217.3% | -138.8% | -74.0% | -78.9% | -137.6% | -348.6% |
| Net Profit Margin | -232.0% | -137.6% | -79.6% | -95.1% | -121.5% | -318.9% |
| Return on Equity (ROE) | -- | -2120.9% | -111.6% | -92.0% | -43.4% | -- |
| Return on Assets (ROA) | -187.4% | -73.1% | -35.8% | -42.6% | -26.5% | -- |
| Current Ratio | 0.27x | 1.09x | 3.55x | 4.32x | 4.70x | -- |
| Quick Ratio | 0.24x | 0.94x | 2.60x | 3.96x | 4.56x | -- |
| Debt to Equity | -- | 11.96x | 0.88x | 0.03x | 0.03x | -- |
| Revenue Growth (YoY) | -27.4% | -15.8% | -21.4% | +42.9% | +99.2% | -- |
| Gross Profit Growth (YoY) | -9.6% | -44.4% | -26.5% | +54.9% | +212.6% | -- |
| 5Y Revenue / Share Growth | -18.5% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.